Korean study monitors fungal drug safety
NCT ID NCT04744454
First seen May 04, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study looked at how safe and effective the drug Cresemba is for adults with serious fungal infections like invasive aspergillosis or mucormycosis. It involved 94 people in Korea who were already prescribed the drug. The main goal was to track any side effects and see if the treatment worked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCORMYCOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Korea
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.